BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)’s share price traded down 5.6% during trading on Wednesday . The company traded as low as $2.19 and last traded at $2.19. 22,628 shares changed hands during mid-day trading, an increase of 1,117% from the average session volume of 1,859 shares. The stock had previously closed at $2.32.
BriaCell Therapeutics Stock Down 5.6 %
The company has a market capitalization of $1.69 million, a P/E ratio of -0.57 and a beta of 1.09. The business has a fifty day moving average price of $2.88 and a 200 day moving average price of $3.97.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
See Also
- Five stocks we like better than BriaCell Therapeutics
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- High-Yield Texas Instruments Could Hit New Highs Soon
- Technology Stocks Explained: Here’s What to Know About Tech
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
